{"cursor":"12642","size":15,"audio":[],"currentlang":"en","article":"'Antibody Drug Conjugates' or ADCs are a new class of highly potent\nbiopharmaceutical drugs designed as a Targeted therapy for the treatment of\npeople with cancer. Antibody-Drug Conjugates: Guided Missiles Deployed\nAgainst Cancerous Cells [http://www.onclive.com/publications/oncology-live/2012/june-2012/Antibody-\nDrug-Conjugates-Guided-Missiles-Deployed-Against-Cancerous-Cells] What\nare ADCs? \"ADC Review / Journal of Antibody-drug Conjugates\", - June 1, 2013 [http://adcreview.com/page/what-are-adcs-antibody-drug-\nconjugates] The Next Advancements in Cancer Drug Development: Antibody-\nDrug Conjugates - Onco'Zine - The International Cancer Network, June 14, 2012\n[http://oncozine.com/profiles/blogs/the-next-advancements-in-cancer-drug-\ndevelopment-antibody-drug-co] [http://pharmtech.findpharma-\n.com/pharmtech/Ingredients+Insider/Antibody-Drug-Conjugates-A-Marriage-of-\nBiologics-a/ArticleStandard/Article/detail/522139 Antibody Drug Conjugates: A\nMarriage of Biologics and Small Molecules - Pharmaceutical Technology].\nPharmtech.findpharma.com. Retrieved on 2010-11-\n20. ADCs are complex molecules composed\nof an antibody (a whole mAb or an antibody fragment such as a single-chain\nvariable fragment [scFv]) linked, via a stable, chemical, linker with labile\nbonds, to a biological active cytotoxic (anticancer) payload or drug. [http://www.genengnews.com/analysis-and-insight/antibody-drug-\nconjugates-stage-a-comeback/77899350/ Antibody-Drug Conjugates Stage a\nComeback] Antibody Drug Conjugates are examples of bioconjugates and\nimmunoconjugates.\n\nBy combining the unique targeting capabilities of a monoclonal antibodies with\nthe cancer-killing ability of a cytotoxic drugs, antibody-drug conjugates allow\nsensitive discrimination between healthy and diseased tissue. This means that,\nin contrast to traditional chemotherapeutic agents, antibody-drug conjugates\ntarget and attack the cancer cell so that healthy cells are less severely\naffected. DiJoseph JF, Armellino DC, Boghaert ER, Khandke K, Dougher MM,\nSridharan L, et al. Antibody-targeted chemotherapy with CMC-544: a CD22-targeted\nimmunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies.\nBlood. 2004 Mar 1;103(5):1807-14. Epub 2003 Nov 13.\n[http://www.ncbi.nlm.nih.gov/pubmed/14615373] Mullard A. Maturing\nantibodyâdrug conjugate pipeline hits 30. Nature Reviews Drug Discovery 12,\n329â332 (May 2013) doi:10.1038/nrd4009\n[http://www.nature.com/nrd/journal/v12/n5/full/nrd4009.html]\n","linknr":199,"url":"antibody-drug_conjugate","recorded":1376420410,"links":["/w/index.php?title=Antibody-drug_conjugate&action=edit","/w/index.php?title=Antibody-drug_conjugate&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Antibody-drug_conjugate","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/Targeted_therapy","#cite_note-1","#cite_note-2","#cite_note-3","#cite_note-arnum-4","#cite_note-5","#cite_note-6","#cite_note-7","/wiki/Antibody","/wiki/Single-chain_variable_fragment","/wiki/Cytotoxic","#cite_note-8","/wiki/Bioconjugate","/wiki/Immunoconjugate","#cite_note-9","#cite_note-10","#How_do_ADCs_work.3F","#Market_Approval","#Linker_technology","#Other_disease_areas","#References","/w/index.php?title=Antibody-drug_conjugate&action=edit&section=1","/w/index.php?title=Antibody-drug_conjugate&veaction=edit&section=1","//upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/40px-Edit-clear.svg.png","/wiki/Wikipedia:TONE","/wiki/Wikipedia:Guide_to_writing_better_articles","#cite_note-Chari1992-11","/wiki/Therapeutic_window","/wiki/New_York_Times","#cite_note-NYT-12","#cite_note-NYT2-13","/w/index.php?title=Antibody-drug_conjugate&action=edit&section=2","/w/index.php?title=Antibody-drug_conjugate&veaction=edit&section=2","/wiki/Food_and_Drug_Administration","/wiki/Acute_myelogenous_leukemia","/wiki/Gemtuzumab_ozogamicin","#cite_note-14","/wiki/Brentuximab_vedotin","/wiki/Trastuzumab_emtansine","/wiki/Brentuximab_vedotin","/wiki/U.S._Food_and_Drug_Administration","/wiki/Trastuzumab_emtansine","#cite_note-15","#cite_note-16","#cite_note-17","/w/index.php?title=Antibody-drug_conjugate&action=edit&section=3","/w/index.php?title=Antibody-drug_conjugate&veaction=edit&section=3","/wiki/Brentuximab_vedotin","/wiki/Monomethyl_auristatin_E","/wiki/Tumor_necrosis_factor","/wiki/Trastuzumab_emtansine","/wiki/Maytansine","#cite_note-18","/wiki/Edman_degradation","#cite_note-19","#cite_note-20","#cite_note-21","#cite_note-22","/w/index.php?title=Antibody-drug_conjugate&action=edit&section=4","/w/index.php?title=Antibody-drug_conjugate&veaction=edit&section=4","#cite_note-23","#cite_note-24","/w/index.php?title=Antibody-drug_conjugate&action=edit&section=5","/w/index.php?title=Antibody-drug_conjugate&veaction=edit&section=5","#cite_ref-1","http://www.onclive.com/publications/oncology-live/2012/june-2012/Antibody-Drug-Conjugates-Guided-Missiles-Deployed-Against-Cancerous-Cells","#cite_ref-2","http://adcreview.com/page/what-are-adcs-antibody-drug-conjugates","#cite_ref-3","http://oncozine.com/profiles/blogs/the-next-advancements-in-cancer-drug-development-antibody-drug-co","#cite_ref-arnum_4-0","http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Antibody-Drug-Conjugates-A-Marriage-of-Biologics-a/ArticleStandard/Article/detail/522139","#cite_ref-5","/wiki/Digital_object_identifier","http://dx.doi.org/10.1021%2Fbc9002019","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/19769391","#cite_ref-6","/wiki/Digital_object_identifier","http://dx.doi.org/10.1158%2F0008-5472.CAN-05-3973","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16540673","/wiki/Help:CS1_errors#displayauthors","#cite_ref-7","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2Fj.canlet.2007.04.010","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17553616","#cite_ref-8","http://www.genengnews.com/analysis-and-insight/antibody-drug-conjugates-stage-a-comeback/77899350/","#cite_ref-9","http://www.ncbi.nlm.nih.gov/pubmed/14615373","#cite_ref-10","http://www.nature.com/nrd/journal/v12/n5/full/nrd4009.html","#cite_ref-Chari1992_11-0","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/1727373","#cite_ref-NYT_12-0","http://www.nytimes.com/2012/06/01/business/a-new-class-of-cancer-drugs-may-be-less-toxic.html?pagewanted=all","#cite_ref-NYT2_13-0","http://www.nytimes.com/interactive/2012/06/02/health/research/Ferrying-a-Drug-Into-a-Cancer-Cell.html?src=tp&smid=fb-share","#cite_ref-14","http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm216458.htm","#cite_ref-15","http://www.gene.com/media/press-releases/14347/2013-02-22/fda-approves-genentechs-kadcyla-ado-tras","#cite_ref-16","http://www.toxicology.org/isot/rc/NorthernCal/2010Spring/2010_6SafetyAntibodyDrugConjugates.pdf","#cite_ref-17","http://www.cancer.gov/drugdictionary/?CdrID=564399","#cite_ref-18","http://www.ncbi.nlm.nih.gov/pubmed/17553616","#cite_ref-19","http://www.ncbi.nlm.nih.gov/pubmed/23690169","#cite_ref-20","http://www.ncbi.nlm.nih.gov/pubmed/22988081","#cite_ref-21","http://www.ncbi.nlm.nih.gov/pubmed/23724085","#cite_ref-22","http://www.ncbi.nlm.nih.gov/pubmed/22612698","#cite_ref-23","http://www.ncbi.nlm.nih.gov/pubmed/23253133","#cite_ref-24","http://www.ambrx.com/about-ambrx/06-18-2012.aspx","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Antibody-drug_conjugate&oldid=567605468","/wiki/Help:Category","/wiki/Category:Antineoplastic_drugs","/wiki/Category:Biotechnology","/wiki/Category:Chemotherapeutic_adjuvants","/wiki/Category:Pages_using_citations_with_old-style_implicit_et_al.","/wiki/Category:Wikipedia_articles_needing_style_editing_from_August_2013","/wiki/Category:All_articles_needing_style_editing","/w/index.php?title=Special:UserLogin&returnto=Antibody-drug+conjugate&type=signup","/w/index.php?title=Special:UserLogin&returnto=Antibody-drug+conjugate","/wiki/Antibody-drug_conjugate","/wiki/Talk:Antibody-drug_conjugate","#","/wiki/Antibody-drug_conjugate","/w/index.php?title=Antibody-drug_conjugate&action=edit","/w/index.php?title=Antibody-drug_conjugate&veaction=edit","/w/index.php?title=Antibody-drug_conjugate&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Antibody-drug_conjugate","/wiki/Special:RecentChangesLinked/Antibody-drug_conjugate","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Antibody-drug_conjugate&oldid=567605468","/w/index.php?title=Antibody-drug_conjugate&action=info","//www.wikidata.org/wiki/Q4774572","/w/index.php?title=Special:Cite&page=Antibody-drug_conjugate&id=567605468","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Antibody-drug+conjugate","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Antibody-drug+conjugate&oldid=567605468&writer=rl","/w/index.php?title=Antibody-drug_conjugate&printable=yes","#","//www.wikidata.org/wiki/Q4774572#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Antibody-drug_conjugate","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":["http://www.toxicology.org/isot/rc/NorthernCal/2010Spring/2010_6SafetyAntibodyDrugConjugates.pdf"],"categories":["Antineoplastic drugs","Biotechnology","Chemotherapeutic adjuvants"],"headings":["How do ADCs work?","Market Approval","Linker technology","Other disease areas","References"],"image":["//upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/40px-Edit-clear.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Targeted_therapy","Antibody","Single-chain_variable_fragment","Cytotoxic","Bioconjugate","Immunoconjugate","Therapeutic_window","New_York_Times","Food_and_Drug_Administration","Acute_myelogenous_leukemia","Gemtuzumab_ozogamicin","Brentuximab_vedotin","Trastuzumab_emtansine","Brentuximab_vedotin","U.S._Food_and_Drug_Administration","Trastuzumab_emtansine","Brentuximab_vedotin","Monomethyl_auristatin_E","Tumor_necrosis_factor","Trastuzumab_emtansine","Maytansine","Edman_degradation"]}